Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (3059)	3/26/1998 9:12:00 AM
From: Dauntless	Read Replies (2) \| Respond to of 7041

Princess - please don't be annoyed. <<<insiders (like Dauntless and Claud?) were buying because they expected the patent approval to come through. Yeah, I'm still annoyed at that.>>> I haven't bought or sold any Zonagen shares during the last two weeks. I know I told Steve "THEY DID NOT" Salgo that I helped support the stock price but, just between you & I, I lied about that. I admit that I listed the patent issuance as a potentially positive event on the near horizon - but that prediction rested on the amount of time since the application went in AND company statements that they were confident the patent would issue. Likewise, I was predicting "international regulatory filings" - that was common sense as they were ready to file in Mexico over a year ago. With all due respect, your highness, perhaps my advantage is that I BELIEVE what Joe & management says - it's that simple. Perhaps the royal ears & mind should consider the same strategy. A recent post of yours hints that this event may have caused you to rethink the honesty of Zonagen's pronouncements. Respectfully Your Loyal Servant

To: Linda Kaplan who wrote (3059)	3/26/1998 9:33:00 AM
From: Brander	Read Replies (1) \| Respond to of 7041

Linda, got up on the wrong side of the bed, saw your post and fired off a quick response....hehehe...sorry. My position concerning the new patent is this. I was leaning short. I did not think the patent was going to be approved because I didn't think Vasomax was unique enough. The patent office seems to think that Vasomax is special enough to deserve a patent. This has, for now, changed my point of view. Although the patent itself will not directly have any influence (or shouldn't)on the FDA decision, the fact that Vasomax appears to be unique and different from anything else could be significant in the decision. Of course, it also has to be effective and safe. Brad